Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 12.00K | 0.00 | 540.17K | 1.42M | 417.45K |
Gross Profit | 12.00K | -88.08K | 535.79K | 739.07K | 106.65K |
EBITDA | -18.50M | -13.55M | -11.38M | -8.48M | -2.58M |
Net Income | -18.46M | -48.81M | -10.29M | -8.53M | -3.24M |
Balance Sheet | |||||
Total Assets | 17.05M | 23.78M | 26.15M | 7.00M | 2.92M |
Cash, Cash Equivalents and Short-Term Investments | 5.86M | 22.12M | 25.80M | 6.84M | 2.49M |
Total Debt | 373.00K | 521.00K | 0.00 | 0.00 | 0.00 |
Total Liabilities | 5.83M | 2.96M | 1.39M | 566.17K | 736.35K |
Stockholders Equity | 11.22M | 20.82M | 24.76M | 6.44M | 2.17M |
Cash Flow | |||||
Free Cash Flow | -16.12M | -11.06M | -8.84M | -5.18M | -2.70M |
Operating Cash Flow | -15.85M | -10.75M | -8.84M | -5.18M | -2.70M |
Investing Cash Flow | -277.00K | -316.00K | 0.00 | 22.00K | 8.93K |
Financing Cash Flow | 0.00 | 8.18M | 28.33M | 9.30M | 5.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
58 Neutral | $75.14M | ― | -38.40% | ― | -11.42% | 89.01% | |
55 Neutral | $180.89M | ― | -57.22% | ― | -27.40% | -475.41% | |
53 Neutral | $50.86M | ― | -10.79% | ― | 11.34% | 71.13% | |
51 Neutral | $7.83B | -0.18 | -40.10% | 2.29% | 21.46% | -2.03% | |
39 Underperform | $69.38M | ― | -201.88% | ― | ― | ― | |
― | $174.04M | 0.07 | -22.50% | ― | ― | ― | |
33 Underperform | $165.27M | ― | -35.88% | ― | ― | ― |
On March 13, 2025, Incannex Healthcare Inc. repaid its outstanding 10% Original Issue Discount Senior Secured Convertible Debenture in full, which was initially issued under a Securities Purchase Agreement with Arena Special Opportunities (Offshore) Master II LP on September 6, 2024. This repayment, amounting to $3,851,111.00, led to the termination of the Debenture Purchase Agreement and related Security Documents, except for indemnification and registration rights. The company’s actions reflect a strategic financial decision that impacts its financial obligations and contractual relationships, with certain warrants and registration rights agreements remaining in effect.